Search: onr:"swepub:oai:hhs.se:1164981880006056" >
Cost-Effectiveness ...
Cost-Effectiveness of Pneumococcal Vaccination of Older People: A Study in 5 Western European Countries
-
- Ament, A (author)
- Karolinska Institutet,Maastricht University,Danderyds sjukhus,Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
-
- Baltussen, R (author)
- Maastricht University
-
- Duru, G (author)
- Laboratoire d'Analyse des Systèmes de Santé,University of Antwerp
-
show more...
-
- Rigaud-Bully, C (author)
- Laboratoire d'Analyse des Systèmes de Santé
-
- de Graeve, D (author)
- University of Antwerp
-
- örtqvist, Å (author)
- Danderyds sjukhus
-
- Jönsson, B (author)
- Stockholm School of Economics,Handelshögskolan i Stockholm
-
- Verhaegen, J (author)
- University Hospital Leuven
-
- Gaillat, J (author)
- Hospital Center
-
- Christie, P (author)
- Health Protection Scotland
-
- Cifre, A. Salazar (author)
- Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
-
- Vivas, D (author)
- University of Valencia
-
- Loiseau, C (author)
- Aventis Pasteur MSD
-
- Fedson, D. S (author)
- Aventis Pasteur MSD
-
show less...
-
(creator_code:org_t)
- The University of Chicago Press, 2000
- 2000
- English.
-
In: Clinical infectious diseases. - : The University of Chicago Press. - 1537-6591 .- 1058-4838. ; 31:2, s. 444-450
- Related links:
-
https://research.hhs... (primary) (Object in context)
-
show more...
-
https://academic.oup...
-
https://research.hhs...
-
https://doi.org/10.1...
-
http://kipublication...
-
show less...
Abstract
Subject headings
Close
- Pneumococcal vaccination of older persons is thought to be cost-effective in preventing pneumococcal pneumonia, but evidence of clinical protection is uncertain. Because there is better evidence of vaccination effectiveness against invasive pneumococcal disease, we determined the cost-effectiveness of pneumococcal vaccination of persons aged ≥65 years in preventing hospital admission for both invasive pneumococcal disease and pneumococcal pneumonia in 5 western European countries. In the base case analyses, the cost-effectiveness ratios for preventing invasive disease varied from ∼11,000 to ∼33,000 European currency units (ecu) per quality-adjusted life year (QALY). Assuming a common incidence (50 cases per 100,000) and mortality rate (20%-40%) for invasive disease, the cost-effectiveness ratios were <12,000 ecu per QALY in all 5 countries. For preventing pneumococcal pneumonia, vaccinating all elderly persons would be highly cost-effective to cost saving. Public health authorities should consider policies for encouraging pneumococcal vaccination for all persons aged ≥65 years.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Hälsovetenskap -- Hälso- och sjukvårdsorganisation, hälsopolitik och hälsoekonomi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Health Sciences -- Health Care Service and Management, Health Policy and Services and Health Economy (hsv//eng)
Publication and Content Type
- art (subject category)
- ref (subject category)
Find in a library
To the university's database
- By the author/editor
-
Ament, A
-
Baltussen, R
-
Duru, G
-
Rigaud-Bully, C
-
de Graeve, D
-
örtqvist, Å
-
show more...
-
Jönsson, B
-
Verhaegen, J
-
Gaillat, J
-
Christie, P
-
Cifre, A. Salaza ...
-
Vivas, D
-
Loiseau, C
-
Fedson, D. S
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Health Sciences
-
and Health Care Serv ...
- Articles in the publication
-
Clinical infecti ...
- By the university
-
Stockholm School of Economics
-
Karolinska Institutet